The Clorox Company (CLX)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $13.26B
Last updated: Nov 17, 2026 at 11:05 AM ET
The Clorox Company (CLX) Financials: Revenue, Profit and Cash Flow
The Clorox Company reported revenue of $6.72B for the fiscal year ended Jun 30, 2026, down 5.4% from the year before. That year, net income was $601.00M with a net margin of 8.9%, operating cash flow was $612.00M and free cash flow was $405.00M. The quarter ended Sep 30, 2026 had revenue of $1.91B and net income of $173.00M.
Revenue and Margins
The operating margin was 13.6% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $5.97B, a compound annual rate of 1.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $6.72B | -5.4% | 42.3% | 13.6% | 8.9% |
| Jun 2025 | $7.10B | +0.2% | 45.2% | 15.2% | 11.6% |
| Jun 2024 | $7.09B | -4.0% | 43.0% | 9.6% | 4.1% |
| Jun 2023 | $7.39B | +4.0% | 39.4% | 5.5% | 2.2% |
| Jun 2022 | $7.11B | -3.2% | 35.8% | 10.6% | 6.6% |
| Jun 2021 | $7.34B | +9.2% | 43.6% | 12.6% | 9.8% |
| Jun 2020 | $6.72B | +8.2% | 45.6% | 19.0% | 14.0% |
| Jun 2019 | $6.21B | +1.5% | 43.9% | 18.1% | 13.2% |
| Jun 2018 | $6.12B | +2.5% | 43.7% | 18.5% | 13.4% |
| Jun 2017 | $5.97B | N/A | 44.7% | 18.9% | 11.7% |
Income Statement
In the fiscal year ended Jun 2026, net income fell 27.1% from the year before. In the quarter ended Sep 2026, net income rose 111.0% from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.72B | $7.10B | $7.09B | $7.39B | $7.11B | $7.34B | $6.72B | $6.21B | $6.12B | $5.97B |
| Cost of revenue | $3.88B | $3.89B | $4.04B | $4.48B | $4.56B | $4.14B | $3.66B | $3.49B | $3.45B | $3.30B |
| Gross profit | $2.84B | $3.21B | $3.05B | $2.91B | $2.54B | $3.20B | $3.06B | $2.73B | $2.67B | $2.67B |
| Research and development | $116.00M | $121.00M | $126.00M | $138.00M | $132.00M | $149.00M | $145.00M | $136.00M | $132.00M | $135.00M |
| Operating income | $913.00M | $1.08B | $683.00M | $408.00M | $750.00M | $927.00M | $1.27B | $1.12B | $1.14B | $1.13B |
| Net income | $601.00M | $824.00M | $292.00M | $161.00M | $471.00M | $719.00M | $939.00M | $820.00M | $823.00M | $701.00M |
| EBITDA | $1.14B | $1.36B | $694.00M | $564.00M | $937.00M | $1.21B | $1.46B | $1.30B | $1.30B | $1.28B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.91B | $1.95B | $1.67B | $1.67B | $1.43B | $1.99B | $1.67B | $1.69B | $1.76B | $1.90B | $1.81B | $1.99B |
| Gross profit | $770.00M | $804.00M | $722.00M | $722.00M | $596.00M | $924.00M | $744.00M | $738.00M | $807.00M | $884.00M | $766.00M | $866.00M |
| Operating income | $261.00M | $258.00M | $289.00M | $241.00M | $125.00M | $425.00M | $243.00M | $236.00M | $176.00M | $317.00M | -$22.00M | $326.00M |
| Net income | $173.00M | $167.00M | $191.00M | $161.00M | $82.00M | $336.00M | $191.00M | $194.00M | $103.00M | $221.00M | -$50.00M | $96.00M |
Balance Sheet
As of Jun 2026, total debt of $5.07B exceeded cash and equivalents by $4.92B.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.79B | $5.56B | $5.75B | $5.95B | $6.16B | $6.33B | $6.21B | $5.12B | $5.06B | $4.57B |
| Current assets | $1.82B | $1.61B | $1.62B | $1.83B | $1.73B | $1.83B | $2.02B | $1.30B | $1.31B | $1.51B |
| Cash and equivalents | $143.00M | $167.00M | $202.00M | $367.00M | $183.00M | $319.00M | $871.00M | $111.00M | $131.00M | $418.00M |
| Total liabilities | $7.54B | $5.08B | $5.26B | $5.56B | $5.43B | $5.74B | $5.30B | $4.56B | $4.33B | $4.03B |
| Short-term debt | $1.09B | $4.00M | $4.00M | $50.00M | $237.00M | $300.00M | $0 | $396.00M | $199.00M | $804.00M |
| Long-term debt | $3.98B | $2.48B | $2.48B | $2.48B | $2.47B | $2.48B | $2.78B | $2.29B | $3.06B | $2.16B |
| Shareholder equity | $90.00M | $321.00M | $328.00M | $220.00M | $556.00M | $411.00M | $908.00M | $559.00M | $726.00M | $542.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.83B | $7.79B | $6.44B | $5.61B | $5.53B | $5.56B | $5.51B | $5.58B | $5.50B | $5.75B | $5.80B | $5.91B |
| Total liabilities | $7.71B | $7.54B | $6.34B | $5.58B | $5.39B | $5.08B | $5.32B | $5.46B | $5.27B | $5.26B | $5.55B | $5.69B |
| Cash and equivalents | $184.00M | $143.00M | $1.19B | $227.00M | $166.00M | $167.00M | $226.00M | $290.00M | $278.00M | $202.00M | $219.00M | $355.00M |
| Shareholder equity | -$39.00M | $90.00M | -$67.00M | -$125.00M | -$22.00M | $482.00M | $27.00M | -$41.00M | $60.00M | $492.00M | $91.00M | $53.00M |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 66.2% of operating cash flow. Dividends and share repurchases together came to 215.8% of it.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $612.00M | $981.00M | $695.00M | $1.16B | $786.00M | $1.28B | $1.55B | $992.00M | $976.00M | $865.00M |
| Capital expenditures | $207.00M | $220.00M | $212.00M | $228.00M | $251.00M | $331.00M | $254.00M | $206.00M | $194.00M | $231.00M |
| Free cash flow | $405.00M | $761.00M | $483.00M | $930.00M | $535.00M | $945.00M | $1.29B | $786.00M | $782.00M | $634.00M |
| Dividends paid | $618.00M | $618.00M | $611.00M | $598.00M | $586.00M | $589.00M | $533.00M | $490.00M | $450.00M | $412.00M |
| Share repurchases | $256.00M | $332.00M | $0 | $0 | $25.00M | $905.00M | $248.00M | $661.00M | $271.00M | $183.00M |
| Investing cash flow | -$2.30B | -$94.00M | -$175.00M | -$223.00M | -$229.00M | -$452.00M | -$252.00M | -$196.00M | -$859.00M | -$205.00M |
| Financing cash flow | $1.67B | -$924.00M | -$655.00M | -$753.00M | -$689.00M | -$1.39B | -$523.00M | -$815.00M | -$399.00M | -$645.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $143.00M | $330.00M | -$122.00M | $311.00M | $93.00M | $294.00M | $286.00M | $180.00M | $221.00M | $340.00M | $182.00M | $153.00M |
| Capital expenditures | $38.00M | $86.00M | $43.00M | $42.00M | $36.00M | $75.00M | $53.00M | $53.00M | $39.00M | $81.00M | $55.00M | $52.00M |
| Free cash flow | $105.00M | $244.00M | -$165.00M | $269.00M | $57.00M | $219.00M | $233.00M | $127.00M | $182.00M | $259.00M | $127.00M | $101.00M |
Frequently Asked Questions About CLX
What is The Clorox Company's annual revenue?
The Clorox Company reported revenue of $6.72B for the fiscal year ended Jun 30, 2026.
How fast is The Clorox Company's revenue growing?
Revenue was down 5.4% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -3.1%.
Is The Clorox Company profitable?
Yes. The Clorox Company reported net income of $601.00M for the fiscal year ended Jun 30, 2026, with a net margin of 8.9%.
How much free cash flow does CLX generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $612.00M minus capital expenditures of $207.00M produced free cash flow of $405.00M.
How much debt does The Clorox Company have?
The balance sheet dated Jun 30, 2026 reported long-term debt of $3.98B, short-term debt of $1.09B and cash and equivalents of $143.00M.
CLX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors